WallStreetZenWallStreetZen

NASDAQ: AMGN
Amgen Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Amgen earnings were $4.1B for the trailing 12 months ending Dec 31, 2024, with -39.3% growth year over year. The latest AMGN earnings report on Dec 31, 2024 announced Q4 2024 earnings of $627.0M, down 77.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AMGN reported annual earnings of $4.1B, with -39.1% growth. The next AMGN earnings date is May 1, 2025.

AMGN past earnings growth

How has AMGN's earnings growth performed historically?

Company
-39.33%
Industry
357.42%
Market
63.87%
AMGN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
AMGN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
AMGN's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

AMGN earnings history

Current Revenue
$33.4B
Current Earnings
$4.1B
Current Profit Margin
12.2%
AMGN's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

AMGN Return on Equity

Current Company
67.2%
Current Industry
40.7%
Current Market
34.1%
AMGN's Return on Equity (67.2%)... subscribe to Premium to read more.
High Return on Equity Performance

AMGN undefined

Current Company
4.5%
Current Industry
8.3%
AMGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AMGN announces earnings.

AMGN undefined

Current Company
11.29%
Current Industry
14.7%
AMGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AMGN vs General Drug Manufacturer Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AMGN$13.36B$4.09B-10.08%$7.62
SNY$11.90B$5.79B+13.35%$2.31
GILD$4.44B$480.00M-38.27%$0.38
PFE$15.02B$8.03B-13.19%$1.42
MRK$25.69B$17.12B+11.98%$6.76
View Top General Drug Manufacturer Stocks

AMGN earnings dates

Next earnings date
May 1, 2025

Amgen Earnings Reports & History FAQ

What were Amgen's earnings last quarter?

On AMGN's earnings call on Invalid Date, Amgen (NASDAQ: AMGN) reported Q4 2024 earnings per share (EPS) of $1.17, up 18.75% year over year. Total AMGN earnings for the quarter were $627.00 million. In the same quarter last year, Amgen's earnings per share (EPS) was $1.44.

If you're new to stock investing, here's how to buy Amgen stock.

When does Amgen report earnings?

The next AMGN earnings date is Invalid Date. Add AMGN to your watchlist to be reminded of Amgen's next earnings date.

What was AMGN's earnings growth in the past year?

As of Amgen's earnings date in Invalid Date, Amgen's earnings has grown -39.33% year over year. This is 396.75 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 357.42%. AMGN earnings in the past year totalled $4.09 billion.

Is Amgen profitable or losing money?

As of the last Amgen earnings report, Amgen is currently profitable. Amgen's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $4.09 billion, a 39.11% decrease year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.